Nanotechnology in Drug Discovery

Author(s): Laksiri Weerasinghe*, Imalka Munaweera* and Senuri Kumarage * .

DOI: 10.2174/9789815238815124010004

Development of Nanomaterials as Drug Candidates

Pp: 66-107 (42)

Buy Chapters

* (Excluding Mailing and Handling)

  • * (Excluding Mailing and Handling)

Abstract

SHS investigation development is considered from the geographical and historical viewpoint. 3 stages are described. Within Stage 1 the work was carried out in the Department of the Institute of Chemical Physics in Chernogolovka where the scientific discovery had been made. At Stage 2 the interest to SHS arose in different cities and towns of the former USSR. Within Stage 3 SHS entered the international scene. Now SHS processes and products are being studied in more than 50 countries.

Abstract

Nanomaterials, with their unique therapeutic traits such as antioxidant, antiinflammatory, antibacterial, antiviral, and anticancer properties, can be used as drug candidates to treat a wide range of diseases. Nano complexes like dendrimers, carbon nanotubes, fullerenes, graphene-based nanomaterials, carbon quantum dots, nanohydrogels, peptide nanostructures, MXenes, Silicene, and Antimonene have been distinguished by researchers, among the many nanomaterials because of their lower toxicity, ease of tuning to the desired end use, complex interactions with biological macromolecules, and solubility properties. This chapter will present the most recent research details on nanomaterials that have been developed as therapeutic candidates to treat a number of illnesses.

We recommend

Favorable 70-S: Investigation Branching Arrow

Authors:Bentham Science Books